COMPANY
MEDI-IoT
Introduction
MEDI-IoT (메디아이오티) is a BT (Bio Technology) convergence company that provides digital prevention/management/treatment solutions in the fields of eye diseases and geriatric diseases. Currently, we offer the eye disease treatment device MEDI-EYE (메디아이) and DTx platform called AgingLOC (에이징락), which diagnoses and provides tailored treatment programs for geriatric diseases. MEDI-IoT provides optimal solutions that meet the needs of customers in the fields of eye diseases and geriatric diseases and has a differentiated approach that sets new standards for treatment. We strive to become a pioneer in the digital healthcare field through continuous research and innovation, and we are committed to improving people's quality of daily life.
History
Signed MOU between Mediiot and NK Medical
Registered 1 Domestic Patent (10-2877512), Completed 1 US Application (19/476,995)
Completed 1 Chinese Patent Application ('202480015045.8)
Secured Investment from ScaleUp Partners
Approved for Exploratory Clinical Trial of MEDI-EYE for Dry Eye Syndrome
Obtained MEDI-EYE-w China SRRC Certification
Obtained ISO 9001 Certification
Obtained MEDI-EYE-w US FCC Certification
Designated as Innovative Medical Device, Obtained MEDI-EYE-w KC Certification
Participated in Hong Kong InnoEx 2024 and Awarded Innovation Prize
Obtained MEDI-EYE KC Certification
Secured Investment from ScaleUp Partners
Participated in CES 2023
Selected for TIPS (Startup Incubating Support Program)
Secured Investment from Hana Securities, Company X
Secured Investment from Daewoong Pharmaceutical
Founded Mediiot, Established Affiliated Research Institute